SCHEMBL12401807

SCHEMBL12401807

Cc1ccc(-c2onc3ccc(C(C)(C)C)cc23)cc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.59
MEN1 O00255 7/20 0.59
KMT2A Q03164 7/20 0.59
KDM4E B2RXH2 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
RAB9A P51151 3/20 0.59
POLB P06746 3/20 0.59
HPGD P15428 3/20 0.59
NPC1 O15118 2/20 0.59
MAPT P10636 2/20 0.59
PTK2B Q14289 1/20 0.59
IP6K1 Q92551 5/20 0.58
IP6K3 Q96PC2 4/20 0.58
IP6K2 Q9UHH9 4/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
HSP90AA1 P07900 1/20 0.49
GFER P55789 1/20 0.46
PIM1 P11309 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12401812 0.87 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL14943768 0.84 ALDH1A1 (0.69) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL13208416 0.77 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL12330213 0.75 ALDH1A1 (0.63) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL6199027 0.75 KDM4E (1.00) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL10396461 0.74 ALDH1A1 (0.66) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL10397089 0.74 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL21305373 0.74 LRRK2 (0.39) ALDH1A1MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL15560352 0.71 PIM1 (0.47) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL21305159 0.68 LRRK2 (0.35) ALDH1A1RAB9AHPGDNPC1IP6K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440706-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-14 US disclosed
US-8372873-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-02-12 US disclosed
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-28 US disclosed
US-7985762-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-07 US disclosed
US-7964624-B1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-21 US disclosed
US-20070179167-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES PRSS1, PRSS3, PRSS2 ALDH1A1 1374/4885MEN1 2930/4885KMT2A 3222/4885
US-20070179167-A1 Inhibitors of serine proteases PRSS1, PRSS3, PRSS2 ALDH1A1 1374/4885MEN1 2930/4885KMT2A 3222/4885
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES PRSS1, SPINT2, PRSS2 ALDH1A1 1255/4885MEN1 3395/4885KMT2A 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.